A clinical trial to compare the effect of methylphenidate and atomoxetine in children with attention deficit hyperactivity disorder

Phase 4

Completed

• Conditions: Health Condition 1: null- Attention Deficit Hyperactivity Disorder

• Registration Number: CTRI/2011/08/001981
• Lead Sponsor: Department of Psychiatry

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2012-05-31
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 69

Inclusion Criteria

Patients from 6 to 15 years of age with the diagnosis of Attention Deficit Hyperactivity Disorder according to Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision.

Patients with moderate to severe illness as assessed by Clinical Global Impressions Severity Scale.

Patients whose parents are willing to provide informed consent for participating in the study.

Exclusion Criteria

Patients with history of non-response or adverse drug reactions to methylphenidate or atomoxetine in the past.

Patients who have taken any medication for ADHD in past one month.

Patients with history of heart disease, seizures, bipolar affective disorder, psychotic illness, pervasive developmental disorder, substance abuse, anxiety, mental retardation or tic disorder.

Study & Design

• Study Type: Interventional
• Study Design: Not specified